The bis(2-pyridylthio)methyl ligand, [Bptm], has been employed in the synthesis of {[Bptm]Zn(μ-F)} 2, a rare example of an organozinc fluoride compound. The dimeric nature of {[Bptm]Zn(μ-F)} 2, which possesses an uncommon [Zn(μ-F)] 2 motif, contrasts with the monomeric structures reported for the other halide derivatives, [Bptm]ZnX (X = Cl, Br, I); this difference is supported by density functional theory calculations which indicate that the fluoride derivative favors a dimeric form with bridging fluoride ligands, whereas the other derivatives favor monomeric structures with terminal halide ligands. {[Bptm]Zn(μ-F)} 2 reacts with Me 3 SiCF 3 to afford the organozinc trifluoromethyl complex, namely [Bptm]ZnCF 3 . The Zn–CF 3 bond in this complex is longer than the Zn–CH 3 bond of the previously reported methyl derivative [Bptm]ZnMe, an observation that is precedented in related zinc compounds but counter to other metal complexes. The infrared frequency corresponding to the asymmetric C–F stretch of [Bptm]ZnCF 3 is unusually low for a metal trifluoromethyl species but is comparable to those for other zinc and cadmium complexes.
No takes yet. Share an insight, caveat, or question.
Shlian et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: